PTC Therapeutics Gets Big Boost From Sarepta's DMD Drug Approval
September 19, 2016 at 12:32 PM EDT
PTC Therapeutics, Inc. (NASDAQ: PTCT) shares received a big boost Monday, thanks to positive tidings received by Sarepta Therapeutics ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.